High-throughput elucidation of thrombus formation reveals sources of platelet function variability

In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the pl...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 104; no. 6; pp. 1256 - 1267
Main Authors van Geffen, Johanna P., Brouns, Sanne L.N., Batista, Joana, McKinney, Harriet, Kempster, Carly, Nagy, Magdolna, Sivapalaratnam, Suthesh, Baaten, Constance C.F.M.J., Bourry, Nikki, Frontini, Mattia, Jurk, Kerstin, Krause, Manuela, Pillitteri, Daniele, Swieringa, Frauke, Verdoold, Remco, Cavill, Rachel, Kuijpers, Marijke J. E., Ouwehand, Willem H., Downes, Kate, Heemskerk, Johan W.M.
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.06.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced α β activation and secretion. Common sequence variation of and , associated with GPVI-induced α β activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.
AbstractList In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced α IIb β 3 activation and secretion. Common sequence variation of GP6 and FCER1G , associated with GPVI-induced α IIb β 3 activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.
In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced α β activation and secretion. Common sequence variation of and , associated with GPVI-induced α β activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.
In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced αIIbβ3 activation and secretion. Common sequence variation of GP6 and FCER1G, associated with GPVI-induced αIIbβ3 activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.
In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced αIIbβ3 activation and secretion. Common sequence variation of GP6 and FCER1G, associated with GPVI-induced αIIbβ3 activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter- and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 microspots, providing 48 parameters of adhesion, aggregation and activation). Microspots triggered platelet activation through GP Ib-V-IX, GPVI, CLEC-2 and integrins. For most thrombus parameters, inter-subject variation was 2-4 times higher than the intra-subject variation. Principal component analyses indicated coherence between the majority of parameters for the GPVI-dependent microspots, partly linked to hematologic parameters, and glycoprotein expression levels. Prediction models identified parameters per microspot that were linked to variation in agonist-induced αIIbβ3 activation and secretion. Common sequence variation of GP6 and FCER1G, associated with GPVI-induced αIIbβ3 activation and secretion, affected parameters of GPVI-and CLEC-2-dependent thrombus formation. Subsequent analysis of blood samples from patients with Glanzmann thrombasthenia or storage pool disease revealed thrombus signatures of aggregation-dependent parameters that were subject-dependent, but not linked to GPVI activity. Taken together, this high-throughput elucidation of thrombus formation revealed patterns of inter-subject differences in platelet function, which were partly related to GPVI-induced activation and common genetic variance linked to GPVI, but also included a distinct platelet aggregation component.
Author Brouns, Sanne L.N.
Pillitteri, Daniele
Baaten, Constance C.F.M.J.
Swieringa, Frauke
Downes, Kate
Cavill, Rachel
Batista, Joana
Jurk, Kerstin
Bourry, Nikki
Verdoold, Remco
Frontini, Mattia
Heemskerk, Johan W.M.
Krause, Manuela
Kuijpers, Marijke J. E.
McKinney, Harriet
Kempster, Carly
Nagy, Magdolna
Sivapalaratnam, Suthesh
Ouwehand, Willem H.
van Geffen, Johanna P.
AuthorAffiliation 6 Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Germany
7 DKD Helios Klinik Wiesbaden, Germany
8 Department of Data Science & Knowledge Engineering, Faculty of Humanities and Sciences, Maastricht University, the Netherlands
5 BHF Centre of Excellence, Division of Cardiovascular Medicine, Cambridge University Hospitals, Cambridge Biomedical Campus, UK
1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands
2 Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, UK
4 The Royal London Haemophilia Centre, London, UK
9 NIHR BioResource, University of Cambridge, Cambridge Biomedical Campus, UK
10 Department of Human Genetics, The Wellcome Sanger Institute, Hinxton, Cambridge, UK
3 National Health Service Blood and Transplant (NHSBT), Cambridge Biomedical Campus, UK
AuthorAffiliation_xml – name: 7 DKD Helios Klinik Wiesbaden, Germany
– name: 10 Department of Human Genetics, The Wellcome Sanger Institute, Hinxton, Cambridge, UK
– name: 5 BHF Centre of Excellence, Division of Cardiovascular Medicine, Cambridge University Hospitals, Cambridge Biomedical Campus, UK
– name: 9 NIHR BioResource, University of Cambridge, Cambridge Biomedical Campus, UK
– name: 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands
– name: 2 Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, UK
– name: 3 National Health Service Blood and Transplant (NHSBT), Cambridge Biomedical Campus, UK
– name: 8 Department of Data Science & Knowledge Engineering, Faculty of Humanities and Sciences, Maastricht University, the Netherlands
– name: 4 The Royal London Haemophilia Centre, London, UK
– name: 6 Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Germany
Author_xml – sequence: 1
  givenname: Johanna P.
  surname: van Geffen
  fullname: van Geffen, Johanna P.
– sequence: 2
  givenname: Sanne L.N.
  surname: Brouns
  fullname: Brouns, Sanne L.N.
– sequence: 3
  givenname: Joana
  surname: Batista
  fullname: Batista, Joana
– sequence: 4
  givenname: Harriet
  surname: McKinney
  fullname: McKinney, Harriet
– sequence: 5
  givenname: Carly
  surname: Kempster
  fullname: Kempster, Carly
– sequence: 6
  givenname: Magdolna
  surname: Nagy
  fullname: Nagy, Magdolna
– sequence: 7
  givenname: Suthesh
  surname: Sivapalaratnam
  fullname: Sivapalaratnam, Suthesh
– sequence: 8
  givenname: Constance C.F.M.J.
  surname: Baaten
  fullname: Baaten, Constance C.F.M.J.
– sequence: 9
  givenname: Nikki
  surname: Bourry
  fullname: Bourry, Nikki
– sequence: 10
  givenname: Mattia
  surname: Frontini
  fullname: Frontini, Mattia
– sequence: 11
  givenname: Kerstin
  surname: Jurk
  fullname: Jurk, Kerstin
– sequence: 12
  givenname: Manuela
  surname: Krause
  fullname: Krause, Manuela
– sequence: 13
  givenname: Daniele
  surname: Pillitteri
  fullname: Pillitteri, Daniele
– sequence: 14
  givenname: Frauke
  surname: Swieringa
  fullname: Swieringa, Frauke
– sequence: 15
  givenname: Remco
  surname: Verdoold
  fullname: Verdoold, Remco
– sequence: 16
  givenname: Rachel
  surname: Cavill
  fullname: Cavill, Rachel
– sequence: 17
  givenname: Marijke J. E.
  surname: Kuijpers
  fullname: Kuijpers, Marijke J. E.
– sequence: 18
  givenname: Willem H.
  surname: Ouwehand
  fullname: Ouwehand, Willem H.
– sequence: 19
  givenname: Kate
  surname: Downes
  fullname: Downes, Kate
– sequence: 20
  givenname: Johan W.M.
  surname: Heemskerk
  fullname: Heemskerk, Johan W.M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30545925$$D View this record in MEDLINE/PubMed
BookMark eNp9kkFv1DAQhS1URLeFf4BQjlyy2E4c2xyQUAW0UiUucLYmjr1x5cSL7azUf49300WUAydLM9-8p_G8K3Qxh9kg9JbgbdPQ9sMIZoIc_JZiIrZECsGaF2hDmKS14JRcoA1uJK47zMUlukrpAWOKpeSv0GWDWVs4tkH9rduNdR5jWHbjfsmV8Yt2A2QX5irY6tiZ-iVVNsRprUZzMOBTlcIStUlHau8hG29yZZdZn6ADRAe98y4_vkYvbeHNm6f3Gv38-uXHzW19__3b3c3n-1q3vM11rztpuaAYcGupIUxgqXuQXFvcdQRYL1sxcA4dsxLwQJgZAKhoDZimLNxco7tVdwjwoPbRTRAfVQCnToUQdwpidtob1bV4wJT3WjJRzK3kmEpBh5ZrTixvitanVWu_9JMZtJlzBP9M9HlndqPahYPqyscKJorA-yeBGH4tJmU1uaSN9zCbsCRFCeMdxw2TBX33t9cfk_ORCvBxBXQMKUVjlXb5dIti7bwiWB0Toc6JUMdEqDURZbj9Z_is_9-x39q2v2w
CitedBy_id crossref_primary_10_1161_ATVBAHA_121_316108
crossref_primary_10_1007_s00018_023_05058_2
crossref_primary_10_1002_rth2_12466
crossref_primary_10_1038_s41598_024_56799_4
crossref_primary_10_3390_ijms20112788
crossref_primary_10_1161_CIRCULATIONAHA_122_059675
crossref_primary_10_3390_s25020491
crossref_primary_10_1371_journal_pone_0299202
crossref_primary_10_3390_ijms222011199
crossref_primary_10_1182_blood_2020009440
crossref_primary_10_1039_D3BM01911J
crossref_primary_10_1002_rth2_12678
crossref_primary_10_3390_ijms23010358
crossref_primary_10_1016_j_thromres_2021_04_014
crossref_primary_10_1055_a_1896_6992
crossref_primary_10_1111_jth_14719
crossref_primary_10_1016_j_thromres_2023_06_001
crossref_primary_10_1111_bjh_18003
crossref_primary_10_3389_fimmu_2020_00078
crossref_primary_10_3390_ijms23158688
crossref_primary_10_1182_bloodadvances_2021006904
crossref_primary_10_1038_s41598_020_78522_9
crossref_primary_10_1016_j_thromres_2022_07_011
crossref_primary_10_1080_09537104_2019_1585526
crossref_primary_10_3390_cells8080846
crossref_primary_10_1182_bloodadvances_2023010027
crossref_primary_10_1097_MOH_0000000000000789
crossref_primary_10_3390_ijms23042046
crossref_primary_10_1161_ATVBAHA_119_313645
crossref_primary_10_3390_ijms21093294
crossref_primary_10_3390_jcm10051114
crossref_primary_10_3390_mi10110787
crossref_primary_10_1016_j_jtha_2022_11_002
crossref_primary_10_3390_ijms23010493
crossref_primary_10_1182_bloodadvances_2020001761
crossref_primary_10_1038_s41598_020_68438_9
crossref_primary_10_1038_s41598_020_68379_3
crossref_primary_10_1042_EBC20180070
crossref_primary_10_1002_rth2_12699
crossref_primary_10_1182_blood_2023021100
crossref_primary_10_1039_D2AN00270A
crossref_primary_10_1055_s_0043_1761463
crossref_primary_10_1182_bloodadvances_2023009860
crossref_primary_10_1038_s41467_021_23909_z
crossref_primary_10_1096_fj_202300360RR
crossref_primary_10_1134_S1990747822030084
crossref_primary_10_3389_fcvm_2019_00099
crossref_primary_10_3389_fimmu_2020_00380
crossref_primary_10_1161_ATVBAHA_121_317092
crossref_primary_10_1016_j_ceca_2023_102738
crossref_primary_10_1016_j_jtha_2023_04_028
crossref_primary_10_1016_j_jtha_2024_04_008
crossref_primary_10_1161_ATVBAHA_122_318767
crossref_primary_10_1186_s12872_024_03907_x
crossref_primary_10_1161_ATVBAHA_120_314641
crossref_primary_10_3934_mbe_2021478
ContentType Journal Article
Copyright Copyright© 2019 Ferrata Storti Foundation.
Copyright© 2019 Ferrata Storti Foundation 2019
Copyright_xml – notice: Copyright© 2019 Ferrata Storti Foundation.
– notice: Copyright© 2019 Ferrata Storti Foundation 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3324/haematol.2018.198853
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1592-8721
EndPage 1267
ExternalDocumentID oai_doaj_org_article_640d027bc958474f9702982d47c71f73
PMC6545858
30545925
10_3324_haematol_2018_198853
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: British Heart Foundation
  grantid: FS/18/53/33863
GroupedDBID ---
29I
2WC
53G
5GY
5RE
5VS
AAFWJ
AAYXX
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GROUPED_DOAJ
H13
HYE
KQ8
OK1
OVT
P2P
RHI
RNS
RPM
SJN
TFS
TR2
UDS
W8F
WOQ
WOW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c474t-bc69f7820a04f2e15809cba97cf0661a5b948d77a65f9a0d15edaa284eae38723
IEDL.DBID DOA
ISSN 0390-6078
1592-8721
IngestDate Wed Aug 27 01:26:56 EDT 2025
Thu Aug 21 18:31:07 EDT 2025
Fri Jul 11 11:12:25 EDT 2025
Mon Jul 21 05:35:29 EDT 2025
Thu Apr 24 23:12:35 EDT 2025
Tue Jul 01 04:22:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright© 2019 Ferrata Storti Foundation.
https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions
Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions
https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-bc69f7820a04f2e15809cba97cf0661a5b948d77a65f9a0d15edaa284eae38723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
KD and JWMH contributed equally to this work.
OpenAccessLink https://doaj.org/article/640d027bc958474f9702982d47c71f73
PMID 30545925
PQID 2157670359
PQPubID 23479
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_640d027bc958474f9702982d47c71f73
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6545858
proquest_miscellaneous_2157670359
pubmed_primary_30545925
crossref_citationtrail_10_3324_haematol_2018_198853
crossref_primary_10_3324_haematol_2018_198853
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190601
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 6
  year: 2019
  text: 20190601
  day: 1
PublicationDecade 2010
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Haematologica (Roma)
PublicationTitleAlternate Haematologica
PublicationYear 2019
Publisher Ferrata Storti Foundation
Publisher_xml – name: Ferrata Storti Foundation
SSID ssj0020997
Score 2.4932961
Snippet In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1256
SubjectTerms Biomarkers
Blood Platelets - metabolism
Flow Cytometry
High-Throughput Screening Assays
Humans
Immunophenotyping
Platelet Activation
Platelet Aggregation
Platelet Count
Platelet Function Tests
Platelet Membrane Glycoproteins - metabolism
Thrombosis - diagnosis
Thrombosis - etiology
Thrombosis - metabolism
Title High-throughput elucidation of thrombus formation reveals sources of platelet function variability
URI https://www.ncbi.nlm.nih.gov/pubmed/30545925
https://www.proquest.com/docview/2157670359
https://pubmed.ncbi.nlm.nih.gov/PMC6545858
https://doaj.org/article/640d027bc958474f9702982d47c71f73
Volume 104
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5KDqWX0iZ9uI-gQunNjW29rGNaGkIhPTWQm5BkiQQ23qW7LuTfd0byLtlSyKVXS0ZCM9J8oxl9A_AxBjwAFOe1711Ti67zuKWkr0Ns0d9qeXK5nM_FD3V-Kb5fyat7pb4oJ6zQA5eFO1GiGdB18sFQQE8ko4k0vBuEDrpNOvN8os3bOlOzq0XvQXP8wKBzhFawPJrjiB5Orh2RoS4p7ND2n9Hn7iXfM0qZu_9fgPPvvMl7hujsGTydESQ7LTN_Do_ieAhHpyOOdnvHPrGc05kvyw_h8cUcOj8CTxkd9VyWZzVtWFxM4aZUVGLLxKjl1k9rtnvOyIjdCbWTlQv-NfVaLRCboqgZ2cPc6Tc624Xr--4FXJ59-_n1vJ4LLNQBl3JT-6BMIsI814jUxVb2jQneGR0SIpHWSW9EP2jtlEzGNUMr4-AcGrToIu91x1_Cwbgc42tg3CXEAsoL1SWhXPQ-OOO5TogJeBd0BXy7wjbM7ONUBGNh0QshuditXCzJxRa5VFDv_loV9o0H-n8h4e36End2_oAaZWeNsg9pVAUftqK3uNcogOLGuJzWFuGRVppIDyt4VVRhNxSem0KaTlag95Rkby77LePNdebzVhS8lP2b_zH5t_AE18OUZLZ3cLD5NcX3CJs2_jjvkON8n_UHlIQWeQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-throughput+elucidation+of+thrombus+formation+reveals+sources+of+platelet+function+variability&rft.jtitle=Haematologica+%28Roma%29&rft.au=van+Geffen%2C+Johanna+P&rft.au=Brouns%2C+Sanne+L+N&rft.au=Batista%2C+Joana&rft.au=McKinney%2C+Harriet&rft.date=2019-06-01&rft.issn=1592-8721&rft.eissn=1592-8721&rft.volume=104&rft.issue=6&rft.spage=1256&rft_id=info:doi/10.3324%2Fhaematol.2018.198853&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon